Chronic skin wounds affect more than 40 million patients globally and represent a severe
growing burden for the healthcare systems, with annual costs expected to exceed $15 …

Drug delivery systems (DDS) are defined as methods by which drugs are delivered to
desired tissues, organs, cells and subcellular organs for drug release and absorption …

In this focused progress review, the recent developments and trends of hydrogel‐forming
microneedles (HFMs) and potential future directions are presented. Previously …

Microneedle (MN) patches consisting of miniature needles have emerged as a promising
tool to perforate the stratum corneum and translocate biomolecules into the dermis in a …

Chronic, non-healing wounds place a significant burden on patients and healthcare
systems, resulting in impaired mobility, limb amputation, or even death. Chronic wounds …

Cell therapies for the treatment of skin disorders could benefit from simple, safe and efficient
technology for the transdermal delivery of therapeutic cells. Conventional cell delivery by …

In recent years, an innovative transdermal delivery technology has attracted great interest for
its ability to distribute therapeutics and cosmeceuticals for several applications, including …

Skin interstitial fluid (ISF) is an emerging source of biomarkers for disease diagnosis and
prognosis. Microneedle (MN) patch has been identified as an ideal platform to extract ISF …

Type 1 and advanced type 2 diabetes treatment involves daily injections or continuous
infusion of exogenous insulin aimed at regulating blood glucose levels in the …

Biodegradable polymer microneedle (MN) arrays are an emerging class of transdermal drug
delivery devices that promise a painless and sanitary alternative to syringes; however …